News Focus
News Focus
icon url

DewDiligence

01/14/11 9:15 AM

#112548 RE: DewDiligence #106172

ABT withdraws BLA/MAA for briakinumab (ABT-874):

http://sec.gov/Archives/edgar/data/1800/000110465911001492/a11-1977_28k.htm

Evidently, the FDA and EMA think more studies are needed to support approval of this compound in psoriasis.